You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
EXPANSION AND GENETIC TRANSDUCTION OF EBV-SPECIFIC CTLS
SBC: Aastrom Biosciences, Inc. Topic: N/ANot Available Differential absorption lidar (DIAL) systems have become extremely useful tools for remote sensing of atmospheric constituents. Physical Sciences Inc. proposes to develop a compact, lightweight, quantum cascade (QC) laser-based DIAL transceiver for remote sensing of airborne chemical compounds. The QC laser-based transmitter will facilitate ground and UAV-based monitoring of trace c ...
SBIR Phase I 1999 Department of Health and Human Services -
MEGAKARYOCYTE EXPANSION FROM MOBILIZED PERIPHERAL BLOOD
SBC: Aastrom Biosciences, Inc. Topic: N/AN/A
SBIR Phase I 1999 Department of Health and Human Services -
STROMAL EFFECTS ON UMBILICAL CORD BLOOD EXPANSION
SBC: Aastrom Biosciences, Inc. Topic: N/AN/A
SBIR Phase I 1999 Department of Health and Human Services -
Dendritic Cell Subset for Enhanced Cancer Vaccine
SBC: Aastrom Biosciences, Inc. Topic: N/ADESCRIPTION (provided by applicant): Tumor antigen primed dendritic cells (DCs) are under widespread clinical evaluation for immunotherapy of multiple forms of cancer. Emerging evidence suggests that DCs are fundamental regulators of the immune response
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Bioreactor for Enhanced T-cell Based Therapy of Melanoma
SBC: Aastrom Biosciences, Inc. Topic: N/ADESCRIPTION (provided by applicant): Malignant melanoma is a significant and deadly form of cancer worldwide. Emerging evidence has shown that melanoma cells express tumor-associated antigens that are specifically recognized by the immune system. Melanom
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
FPIA FOR INDINAVIR AND NELFINAVIR HIV INHIBITORS
SBC: ABACUS DIAGNOSTICS SYSTEMS, INC. Topic: N/ANot Available A terrorist incident involving chemical/biological (CB) weapons may occur as a local event with potentially profound national implications Such an incident may occur at a US military base, a US federal, state or local agency or a civilian entity. Regardless of where the incident has occurred, first responders must be able to provide critical resources within minutes to mitigate the ...
SBIR Phase I 1999 Department of Health and Human Services -
N/A
SBC: ABACUS HEALTH SOLUTIONS, LLC Topic: N/AN/A
SBIR Phase I 1999 Department of Health and Human Services -
N/A
SBC: ABACUS HEALTH SOLUTIONS, LLC Topic: N/AN/A
SBIR Phase II 1999 Department of Health and Human Services -
Novel Caenorhabditis Elegans Reagents
SBC: ABEOME CORPORATION Topic: N/ADESCRIPTION (provided by applicant): C. elegans is well established as a highly useful model organism. The 14th annual Biennial International C. elegans Conference held June 29th-July 3, 2003 elicited over 1151 abstracts published by over 2500 authors
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Novel Markers on Human Embryonic Stem Cells
SBC: ABEOME CORPORATION Topic: N/ADESCRIPTION(provided by applicant): Embryonic stem cells (ES) are a major focus of research, because of their experimental utility and great promise as therapeutic tissue regeneration and gene replacement agents. ES cells are rapidly growing pluripot
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health